These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30445763)

  • 41. Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity.
    Baccon-Sollier PL; Malki Y; Maye M; Ali LMA; Lichon L; Cuq P; Vincent LA; Masurier N
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):935-949. PubMed ID: 32249633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
    El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives.
    Briguglio I; Loddo R; Laurini E; Fermeglia M; Piras S; Corona P; Giunchedi P; Gavini E; Sanna G; Giliberti G; Ibba C; Farci P; La Colla P; Pricl S; Carta A
    Eur J Med Chem; 2015 Nov; 105():63-79. PubMed ID: 26479028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity.
    El Newahie AM; Ismail NS; Abou El Ella DA; Abouzid KA
    Arch Pharm (Weinheim); 2016 May; 349(5):309-26. PubMed ID: 27062086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
    Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
    Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
    El-Hawash SA; Wahab AE
    Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Design and synthesis of quinoxaline derivatives and their antitumor activities].
    Zhao CH; Chen Y; Ding J; Duan WH
    Yao Xue Xue Bao; 2005 Sep; 40(9):814-9. PubMed ID: 16342683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of novel quinoxaline derivatives and its cytotoxic activities.
    Tanimori S; Nishimura T; Kirihata M
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4119-21. PubMed ID: 19539470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
    Alswah M; Bayoumi AH; Elgamal K; Elmorsy A; Ihmaid S; Ahmed HEA
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29280968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity.
    Vitale G; Corona P; Loriga M; Paglietti G
    Farmaco; 1998; 53(8-9):594-601. PubMed ID: 10081824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and in vitro antimalarial activity of a series of bisquinoline and bispyrrolo[1,2a]quinoxaline compounds.
    van Heerden L; Cloete TT; Breytenbach JW; de Kock C; Smith PJ; Breytenbach JC; N'Da DD
    Eur J Med Chem; 2012 Sep; 55():335-45. PubMed ID: 22889556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, biological assessment and molecular docking studies of new 2-aminoimidazole-quinoxaline hybrids as potential anticancer agents.
    Ghanbarimasir Z; Bekhradnia A; Morteza-Semnani K; Rafiei A; Razzaghi-Asl N; Kardan M
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Apr; 194():21-35. PubMed ID: 29310028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
    Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
    Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate Derivatives on Human Leukemia Cells.
    Desplat V; Vincenzi M; Lucas R; Moreau S; Savrimoutou S; Rubio S; Pinaud N; Bigat D; Enriquez E; Marchivie M; Routier S; Sonnet P; Rossi F; Ronga L; Guillon J
    ChemMedChem; 2017 Jun; 12(12):940-953. PubMed ID: 28218826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives.
    Moorthy NS; Karthikeyan C; Trivedi P
    J Enzyme Inhib Med Chem; 2010 Jun; 25(3):394-405. PubMed ID: 20233012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and biological activities of pyrazolo[3,4-g]quinoxaline derivatives.
    Gavara L; Saugues E; Alves G; Debiton E; Anizon F; Moreau P
    Eur J Med Chem; 2010 Nov; 45(11):5520-6. PubMed ID: 20864224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
    Solano B; Junnotula V; Marín A; Villar R; Burguete A; Vicente E; Pérez-Silanes S; Aldana I; Monge A; Dutta S; Sarkar U; Gates KS
    J Med Chem; 2007 Nov; 50(22):5485-92. PubMed ID: 17910426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytotoxic effects of quinoxaline derivatives on human cancer cell lines.
    Yoo HW; Lee YS; Suh ME; Kim DJ; Park SW
    Arch Pharm (Weinheim); 1998 Oct; 331(10):331-3. PubMed ID: 9844581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Synthesis and in vitro cytotoxic activities of sorafenib derivatives].
    Wang K; Li Y; Zhang LJ; Yang HZ; Chen XG; Feng ZQ
    Yao Xue Xue Bao; 2014 May; 49(5):639-43. PubMed ID: 25151734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.
    Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
    J Med Chem; 1997 Jun; 40(13):2053-63. PubMed ID: 9207947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.